CVE:NDVA

0.06
0.00 (0.00%) 1d
0

Related posts

Most Anticipated Earnings: MAI-X, FOOD-T and more Canadian Companies Reporting Earnings this Week (Nov 20-24)One Year of Cannabis Investing: Happy Birthday, Mary Jane!This week’s new 52-week lows… (Dec 05-11)
Investor Insights

This summary was created by AI, based on 2 opinions in the last 12 months.

Experts have conflicting views on the company Indiva. While one expert is positive about their transition into the edibles market and their deal with Canopy, another expert is concerned about the fall in the Canadian cannabis sector and the overvaluation of the industry. Overall, the company seems to be executing well but facing challenges in the current market.

Consensus
Mixed
Valuation
Fair Value
WATCH
Indiva

Are transitioning from growing cannabis into edibles, namely chocolate, including supplying US companies. They have a deal with Canopy. He continues to like it. Down the road, this will be taken out. Great execution.

0
HOLD
Indiva

Market has fallen out for Canadian cannabis sector.
Cannabis sector over valued the past few years.
Demand for product stable, however stock price weak.
Would recommend buying given current share price.
Hold shares if already own.

0
BUY
Indiva
Really good job of executing. Three major partnerships in edibles, more being added. Pivoted away from being a pure cultivator (a low-margin business, littered with bankruptcies) toward higher-margin end product sales. Rinse and repeat. Great market share.
0
COMMENT
Indiva
It has been hard for anyone in the cannabis sector to be patient. Even companies in this sector that have executed well haven't done well. Indiva is doing a great job rolling out new products and is in the top five for cannabis edibles. There has been talk about Canopy taking out their partners in the U.S. and this hasn't helped.
0
BUY
Indiva
Still owns it and is one of the only Canadian cannabis names he still holds. Likes the management. Early on, the CEO realized that flower would offer low margins, so he went to the US to get into edible cannabis, like chocolates and gummi bears with US partners. Now, those products lead in those categories. Revenues are lumpy, because of the provincial board's ordering patterns. Also, NDVA is a small-cap. Over time, they will likely be taken over.
0
Unspecified
Indiva
He owns it in the Cannabis fund. There is an over-capacity in the Canadian market but this has a bit of a different business model with a variety of products and new products. It is quite cheap probably due to some lumpy revenue but the trend is up over a six month period.
0
Unspecified
Indiva
The Cannabis space has had its difficulties so Indiva has pivoted to a manufacturing company. It has done deals in the U.S. and is developing new products. Its products are popular but there was a recent hiccup involving deliveries. The full year should show better results. Eventually it should be taken out. He owns in the Cannabis portfolio.
0
BUY
Indiva

Company has preformed very well the past 2-3 years. Low stock price not indicative of performance. Recently signed distribution agreement for vape product in USA. Indiva might be a good candidate to be taken over via M&A. Good example of a product based marijuana company. Expecting share price to increase as currently under priced.

0
HOLD
Indiva
Loves the management team. Chocolates, gummies are top sellers. 45% market share of all edibles in Canada. Adjusted-EBITDA positive. Seasonal slowdown. Executed well, top brands. Stock needs a catalyst.
0
Showing 1 to 9 of 9 entries
  • «
  • 1
  • »

Indiva(NDVA-X) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Indiva is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Indiva(NDVA-X) Frequently Asked Questions

What is Indiva stock symbol?

Indiva is a Canadian stock, trading under the symbol NDVA-X on the TSX Venture Exchange (NDVA-CV). It is usually referred to as TSXV:NDVA or NDVA-X

Is Indiva a buy or a sell?

In the last year, 1 stock analyst published opinions about NDVA-X. 0 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Indiva.

Is Indiva a good investment or a top pick?

Indiva was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Indiva.

Why is Indiva stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Indiva worth watching?

In the last year, there was no coverage of Indiva published on Stockchase.

What is Indiva stock price?

On 2024-04-19, Indiva (NDVA-X) stock closed at a price of $0.06.